<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Neuropharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Curr Neuropharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">555</journal-id><journal-id journal-id-type="pmc-domain">currneuro</journal-id><journal-id journal-id-type="publisher-id">CN</journal-id><journal-title-group><journal-title>Current Neuropharmacology</journal-title></journal-title-group><issn pub-type="ppub">1570-159X</issn><issn pub-type="epub">1875-6190</issn><publisher><publisher-name>Bentham Science Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10193759</article-id><article-id pub-id-type="pmcid-ver">PMC10193759.1</article-id><article-id pub-id-type="pmcaid">10193759</article-id><article-id pub-id-type="pmcaiid">10193759</article-id><article-id pub-id-type="pmid">35838215</article-id><article-id pub-id-type="doi">10.2174/1570159X20666220714104231</article-id><article-id pub-id-type="publisher-id">CN-21-133</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Medicine, Neurology, Pharmacology, Neuroscience</subject></subj-group></article-categories><title-group><article-title>Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Chiappini</surname><given-names initials="S">Stefania</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ceci</surname><given-names initials="F">Franca</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mosca</surname><given-names initials="A">Alessio</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Carlo</surname><given-names initials="F">Francesco</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burkauskas</surname><given-names initials="J">Julius</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pettorruso</surname><given-names initials="M">Mauro</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martinotti</surname><given-names initials="G">Giovanni</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guirguis</surname><given-names initials="A">Amira</given-names></name><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Corkery</surname><given-names initials="JM">John M.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scherbaum</surname><given-names initials="N">Norbert</given-names></name><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schifano</surname><given-names initials="F">Fabrizio</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Di Giannantonio</surname><given-names initials="M">Massimo</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Neurosciences, Imaging and Clinical Sciences</institution>, <institution>Universit&#224; degli Studi G. D&#8217;Annunzio</institution>, <addr-line>66100 Chieti</addr-line>-<addr-line><city>Pescara</city></addr-line>, <country country="it">Italy</country>;</aff><aff id="aff2"><label>2</label><institution content-type="dept">Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences</institution>, <institution>University of Hertfordshire</institution>, <addr-line><state>Hertfordshire </state></addr-line><addr-line><postal-code>AL10 9AB</postal-code>, <country country="gb">UK</country></addr-line>;</aff><aff id="aff3"><label>3</label><institution content-type="dept">Laboratory of Behavioural Medicine, Neuroscience Institute</institution>, <institution>Lithuanian University of Health Sciences</institution>, <addr-line><postal-code>00142 </postal-code><city>Palanga</city></addr-line>, <country country="lt">Lithuania</country>;</aff><aff id="aff4"><label>4</label><institution content-type="dept">Swansea University Medical School, The Grove</institution>, <institution>Swansea University</institution>, <addr-line><city>Swansea</city>, <postal-code>SA2 8PP</postal-code></addr-line>, <country country="gb">UK</country>;</aff><aff id="aff5"><label>5</label><institution content-type="dept">LVR-Hospital Essen, Department of Addictive Behaviour and Addiction Medicine, Medical Faculty</institution>, <institution>University of Duisburg-Essen</institution>, <addr-line><city>Essen</city></addr-line>, <country country="de">Germany</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Department of Neurosciences, Imaging and Clinical Sciences, Universit&#224; degli Studi G. D&#8217;Annunzio, 66100 Chieti-Pescara, Italy; E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="stefaniachiappini9@gmail.com">stefaniachiappini9@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><day>1</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>1</day><month>1</month><year>2023</year></pub-date><volume>21</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">436083</issue-id><fpage>133</fpage><lpage>141</lpage><history><date date-type="received"><day>29</day><month>5</month><year>2022</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>11</day><month>10</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-17 17:25:29.180"><day>17</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 Bentham Science Publishers</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p> This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</uri>), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CN-21-133.pdf"/><abstract><sec><title>Background</title><p> During the past decade, the misuse of over-the-counter (OTC) medicines has become a global public health concern, especially among young people. In this study, we aimed to explore the OTC consumption and related misuse in Italy and identify the demographic characteristics of people/individuals involved in this phenomenon, understanding eventual risk factors.</p></sec><sec><title>Methods</title><p> The study consisted of an anonymous online survey distributed by direct contact and <italic toggle="yes">via</italic> the Internet between June-November 2021 to the general population living in Italy. Descriptive statistics were reported, and binary regression analyses were performed to identify risk factors for lifetime misuse of OTC. The University of Hertfordshire approved the study (aLMS/SF/UH/02951).</p></sec><sec><title>Results</title><p> The final sample size was composed of 717 respondents. The sample was mainly represented by female (69.3%) students (39.9%) in the 20-25 years age group (30.0%). Based on the survey responses, study participants were divided into two groups according to the presence/absence of OTC abuse/misuse (127 <italic toggle="yes">versus</italic> 590), which were compared for possible predictors of OTC diversion. Multivariate regression showed that OTC abuse/misuse was associated with the knowledge of the effects of OTC [odds ratio/OR = 2.711, 95%Confidence Interval/CI 1.794-4.097, <italic toggle="yes">p &lt;</italic>0.001]. On the contrary, the educational level appeared to be a protective factor [OR = 0.695, 95%CI 0.58&#8211;0.94, <italic toggle="yes">p =</italic> 0.016].</p></sec><sec><title>Conclusion</title><p> Although, according to our data, the phenomenon of OTC abuse appeared to be limited, increasing attention is needed because of possible underestimation and high-risk outcomes. Preventive strategies, including simplified access to information, may play a key role in limiting OTC misuse.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Over-the-counter drugs</kwd><kwd>OTC</kwd><kwd>drug misuse</kwd><kwd>drug diversion</kwd><kwd>survey</kwd><kwd>demographic characteristics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><label>1</label><title>INTRODUCTION</title><sec id="sec1.1"><label>1.1</label><title>The &#8216;Pharming&#8217; Phenomenon</title><p>Over-the-counter medicines (OTC) are drugs that can be purchased from a pharmacy, online stores and supermarkets without a prescription and are available for self-medication, including several products used for the treatments of self-limiting conditions or minor illnesses, <italic toggle="yes">e.g.</italic>, acute sore throat, conjunctivitis, coughs/colds and nasal congestions, diarrhoea, minor pain, travel sickness, <italic toggle="yes">etc</italic>. They are generally considered safe medications; however, some may be harmful due to inappropriate intake, adverse drug reactions, and drug interactions, but also due to dependence and diversion issues [<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r8" ref-type="bibr">8</xref>]. In fact, OTC might be abused and diverted to reach psychoactive recreational effects through idiosyncratic reactions related to unusual routes of administration, high or very-high dosages and a combination of licit/illicit drugs to enhance effects [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref>]. These issues are related to the phenomenon known as <italic toggle="yes">pharming</italic> [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r11" ref-type="bibr">11</xref>] which identifies the possibility of diversion of medicines to achieve psychoactive effects [<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r13" ref-type="bibr">13</xref>]. OTC medications may be easily diverted due to several factors: i) they are ubiquitous and easily available and may be easily purchased at local stores and on the internet; ii) they are often inexpensive; and, finally, iii) they are legal and are perceived to be harmless [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r11" ref-type="bibr">11</xref>]. The most commonly abused OTC include: i) antihistamines, <italic toggle="yes">e.g.</italic>, chlorphenamine, diphenhydramine and dimenhydrinate [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>]; ii) syrups based on codeine and/or promethazine [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r16" ref-type="bibr">16</xref>-<xref rid="r18" ref-type="bibr">18</xref>]; iii) dextromethorphan cough syrups [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r19" ref-type="bibr">19</xref>]; iv) drugs based on ephedrine and pseudoephedrine [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r20" ref-type="bibr">20</xref>]; v) loperamide [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r22" ref-type="bibr">22</xref>]; vi) and benzydamine-based anti-inflammatories [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r24" ref-type="bibr">24</xref>].</p></sec><sec id="sec1.2"><label>1.2</label><title>Current Prevalence of OTC Diversion</title><p>A major problem in assessing the extent of OTC misuse is the limited research on the problem, as it is mostly focused on the abuse of illicit drugs [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r25" ref-type="bibr">25</xref>]. Currently, even though the problem of OTC abuse has been recognized and studied in recent decades [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r26" ref-type="bibr">26</xref>], there is limited information on the prevalence of OTC misuse [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r27" ref-type="bibr">27</xref>]. According to a mixed-method systematic review, the prevalence reported <italic toggle="yes">via</italic> survey questionnaires with pharmacy customers and the general public ranged from 3.1 to 59% for misuse, 0.8 to 4.1% for abuse and 4.2 to 17.8% for dependence, while the prevalence of OTC medicines problematic use reported through national databases was variable, with an overall pooled prevalence in the population-based studies recorded of 16.2% for misuse, 2.0% for abuse, and 7.2% for dependence [<xref rid="r28" ref-type="bibr">28</xref>]. The same review study described analgesics (with or without codeine), sedative antihistamines, and cough mixtures containing dextromethorphan as the groups of OTC drugs most commonly involved in problematic use [<xref rid="r28" ref-type="bibr">28</xref>]. It is possible that the diversion of OTC may be underestimated because of the ease of purchasing OTC, which promotes self-management, which may increase diversion to the inherent abuse potential of some of these OTC medicines [<xref rid="r25" ref-type="bibr">25</xref>]. Indeed, among pharmacists, there are increasing concerns about the possible inappropriate use of OTC in several countries, including the United Kingdom (UK) [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r29" ref-type="bibr">29</xref>, <xref rid="r30" ref-type="bibr">30</xref>] and the United States of America (USA) [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref>]. A further issue is the impact of the CoronaVirus disease (CoViD)-19 pandemic on drug markets, which has introduced numerous changes in drug consumption habits, <italic toggle="yes">e.g.</italic>, an increase in drug amounts used, relapse, or shifts to other substances if access to illicit or other substances previously used has become limited. These changes have been associated with increased internet drug-seeking activities, increased access to websites promoting rogue/illicit pharmaceutical products, such as benzodiazepines, or the use of alternative drugs or medications, including OTC medications [<xref rid="r33" ref-type="bibr">33</xref>-<xref rid="r36" ref-type="bibr">36</xref>].</p></sec><sec id="sec1.3"><label>1.3</label><title>Data Regarding OTC and Self-medication in Italy</title><p>According to the current literature available, there are several data concerning the patterns of use of certain OTC drugs in Italy, <italic toggle="yes">e.g.</italic>, analgesic medications, including both opioids and non-opioids, used for the treatment of headache [<xref rid="r37" ref-type="bibr">37</xref>] or pain in general [<xref rid="r38" ref-type="bibr">38</xref>]. OTC inappropriate use has been recorded mainly in specific categories, such as the elderly [<xref rid="r38" ref-type="bibr">38</xref>] and pregnant women [<xref rid="r39" ref-type="bibr">39</xref>]. A recently published study highlighted the value of the regulatory switch from prescription to non-prescription medicines in Italy, showing that greater availability of non-prescription/OTC drugs could determine a positive economic impact and promote greater adherence to therapy, resulting in more effective prevention or treatment of minor pathologies, but also, conversely, be associated with the risk of the misuse, requiring patient education and training [<xref rid="r40" ref-type="bibr">40</xref>]. Despite of this, the current evidence relating to the prevalence of OTC misuse and dependence in Italy is still limited. Because of this, the extent of OTC misuse in Italy has not been quantified yet, and the types of drugs, modes of misuse, and total number of people affected have not been adequately determined.</p></sec><sec id="sec1.4"><label>1.4</label><title>The Terminology Issue Related to &#8216;Misuse,&#8217; &#8216;Abuse&#8217; and &#8216;Non-medical Use&#8217; of OTC</title><p>Due to the heterogeneity regarding data focusing on prescription drug misuse and the issues in identifying misusing practices and misuse of medicines, in the survey, the terms <italic toggle="yes">non-medical use</italic> or <italic toggle="yes">misuse</italic> or <italic toggle="yes">abuse</italic> in relation to medication are considered as a single phenomenon and used interchangeably, even though referring to specific conditions. As a reference, we could consider the definitions available in the Medical Dictionary for Regulatory Activities-MedDRA (MedDRA) [<xref rid="r41" ref-type="bibr">41</xref>], which is a standardised medical terminology used worldwide in pharmacovigilance, where the term <italic toggle="yes">misuse</italic> describes the intentional use for a therapeutic purpose by a patient or consumer of a product, OTC or prescription, other than as prescribed or not in accordance with the authorised product information. Similarly, the European Monitoring Centre for Drugs and Drug Abuse (EMCDDA) indistinctly uses <italic toggle="yes">diversion</italic>, <italic toggle="yes">misuse</italic>, and <italic toggle="yes">non-medical use</italic> of medications, terms referring to situations where the medicinal product is intentionally and inappropriately used not in accordance with the authorised product information, <italic toggle="yes">e.g.</italic>, a prolonged and continued use of medications, even after the original health problem for which the drug was prescribed has been resolved; or the use of a molecule in amounts exceeding the therapeutic dosage, outside the indications, and in combination with other drugs or medicines [<xref rid="r42" ref-type="bibr">42</xref>]. The National Institute on Drug Abuse (NIDA) uses <italic toggle="yes">drug misuse</italic> to distinguish improper or unhealthy use of medication as prescribed, including the repeated use of drugs to produce pleasure, alleviate stress, and/or alter or avoid reality, using prescription drugs in ways other than prescribed, or using someone else&#8217;s prescription [<xref rid="r43" ref-type="bibr">43</xref>]. Similarly, NIDA uses the term <italic toggle="yes">misuse</italic>, as it is roughly equivalent to the term <italic toggle="yes">abuse</italic>, which is considered a diagnostic term that professionals increasingly avoid because it can be shaming and stigmatizing [<xref rid="r43" ref-type="bibr">43</xref>], whereas the MedDRA considers <italic toggle="yes">drug abuse</italic> the habitual use of drugs that are not needed for therapeutic purposes (<italic toggle="yes">e.g.</italic>, to alter mood); to affect a body function unnecessarily (<italic toggle="yes">e.g.</italic>, laxative); and non-medical use of drugs [<xref rid="r41" ref-type="bibr">41</xref>]. Interestingly, highlighting its consequences, the UK Advisory Council on the Misuse of Drugs (ACMD) characterised <italic toggle="yes">problematic drug use</italic> as a condition that may cause an individual to experience social, psychological, physical, or legal problems related to intoxication and/or regular excessive consumption, and/or dependence [<xref rid="r44" ref-type="bibr">44</xref>]. Indeed, misusing prescription drugs involves risks associated with the drugs themselves and the general context in which they are consumed. These include side effects, interactions between licensed medicines and other unlicensed substances or products (food and environmental chemicals), and individual variation in responses (genetic differences and possible comorbidities), which might be associated with a range of severe adverse reactions and fatalities [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r42" ref-type="bibr">42</xref>, <xref rid="r45" ref-type="bibr">45</xref>, <xref rid="r46" ref-type="bibr">46</xref>].</p><p><italic toggle="yes">Aim of the study</italic>: to explore the OTC consumption and related misuse in Italy and to identify the demographic characteristics of people/individuals involved in this phenomenon, understanding eventual risk factors.</p></sec></sec><sec sec-type="materials|methods" id="sec2"><label>2</label><title>MATERIALS AND METHODS</title><sec id="sec2.1"><label>2.1</label><title>Questionnaire</title><p>The questionnaire used for the survey consisted of 15 multiple-choice questions aiming at collecting socio-demographic information of the participants, investigating the use and possible abuse/misuse of OTC and eventual combination with other substances. The survey included:</p><p>i) general information, such as age, gender, occupation, level of education achieved, country of origin/residence; and ii) information regarding the information about the abuse and misuse of OTC medicines: a) their purchase without a medical indication; b) type of OTC drug, including benzydamine mouth wash, spray, tablet or gel, <italic toggle="yes">e.g.</italic>, Difflam<sup>&#174;</sup>, Tantum Rosa<sup>&#174;</sup>, Rosalgin<sup>&#174;</sup>, and commercial brands; chlorphenamine-containing medicines, <italic toggle="yes">e.g.</italic>, Piriton<sup>&#174;</sup>, Allercalm<sup>&#174;</sup>, Hayleve<sup>&#174;</sup>, Chlortripolon<sup>&#174;</sup>, Panadol<sup>&#174;</sup>, and commercial brands; codeine-containing medicines, <italic toggle="yes">e.g.</italic>, Cocodamol<sup>&#174;</sup>, Nurofen plus<sup>&#174;</sup>, Adcodol<sup>&#174;</sup>, and brand names; loperamide, <italic toggle="yes">e.g.</italic>, Imodium<sup>&#174;</sup>, and brand names; dextromethorphan-containing cough syrups, <italic toggle="yes">e.g.</italic>, Coricidin<sup>&#174;</sup>, Delsym<sup>&#174;</sup>, Dimetapp<sup>&#174;</sup>, Mucinex<sup>&#174;</sup>, Robitussin<sup>&#174;</sup>, Sucrets<sup>&#174;</sup>, Vicks<sup>&#174;</sup>, and store brands; diphenhydramine and dimenhydrinate medications, <italic toggle="yes">e.g.</italic>, Benadryl<sup>&#174;</sup>, Dramamine<sup>&#174;</sup>, and store brands; ephedrine- and pseudoephedrine- containing medications, <italic toggle="yes">e.g.</italic>, ActiPe<sup>&#174;</sup>, Actifed<sup>&#174;</sup>, Sudafed<sup>&#174;</sup>, Claritin-D<sup>&#174;</sup>, Panadol<sup>&#174;</sup>, and store brands; hyoscine butyl bromide products, <italic toggle="yes">e.g.</italic>, Buscopan<sup>&#174;</sup>, and brand names; syrup and tablets containing promethazine, <italic toggle="yes">e.g.</italic>, Phenergan<sup>&#174;</sup>, and commercial brands; c) the effect sought, <italic toggle="yes">e.g.</italic> self-medication, psychoactive effects/recreational purposes, to increase/reduce the effects of concomitant drugs used; d) OTC dosage (<italic toggle="yes">e.g.</italic> above/below indication); e) licit or illicit concomitant substances; f) knowledge on OTC abuse/misuse potential effects and harms; <italic toggle="yes">etc</italic>.</p></sec><sec id="sec2.2"><label>2.2</label><title>Procedure</title><p>The survey was distributed to the general population by direct contact (<italic toggle="yes">e.g.</italic>, acquaintances, students, psychiatrists working in hospitals and addiction centres) and <italic toggle="yes">via</italic> the internet (<italic toggle="yes">e.g.</italic>, emails, social networks, online for, using the link <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://forms.office.com/Pages/ResponsePage.aspx?id=0Lf4QSGaXEGcaaZ5hPPQ3pii9xKYZ8hBlvCtJ6rqdhx" ext-link-type="uri">https://forms.office.com/Pages/ResponsePage.aspx?id=0Lf4QSGaXEGcaaZ5hPPQ3pii9xKYZ8hBlvCtJ6rqdhx</ext-link> UQkFB UV dEMTdPVkZMTTFNMEdaMUZJMVlUUy4u), through the snowball sampling technique [<xref rid="r47" ref-type="bibr">47</xref>], consisting in inviting participants to share the survey with their contacts. Furthermore, researchers encouraged participants to send the link to other participants, helping to reach an adequate study sample. However, the engagement rate was not monitored. Formal online consent was provided for each participant to tick before starting the survey. Participation in the survey was anonymous and free of compensation. The web-based survey platform was Microsoft Forms, which was used to collect the recorded data. Post recruitment, data were securely stored as Microsoft Excel sheets at the University of Chieti (Italy), Department of Neurosciences.</p></sec><sec id="sec2.3"><label>2.3</label><title>Data Collection</title><p>The study was conducted between June 2021 and November 2021 and the survey was administered to the general Italian population from 15 years of age.</p></sec><sec id="sec2.4"><label>2.4</label><title>Statistical Analysis</title><p>All statistical analyses were performed using IBM SPSS windows version 22. Normality checking yielded adequate values. Groups of individuals (non-abusing/misusing <italic toggle="yes">vs.</italic> abusing/misusing) were compared using the Chi-square test with paired Z test and Fisher&#8217;s exact test, as appropriate. Binary logistic regressions were calculated to inspect how education, purchase of OTC drugs without indication and knowledge of OTC drugs misuse/abuse side effects predict the OTC drugs abuse/misuse (classified as 0, &#8220;non-abusing/non-misusing&#8221; or 1, &#8220;abusing/misusing&#8221;), controlling for age, gender, and employment status. Variables considered were dichotomized for the binary regression analysis as follows: Gender &#8211; male (1)/female (2); Employed &#8211; No (0), Yes (1); Purchase Over-the-counter drug without indication &#8211; No (0), Yes (1); Have no knowledge &#8211; have (0), No have/I have never used the previous drugs (1). Factors significant in group comparisons were later included in a single binary regression model. With a given sample size and the number of 6 predictor variables, we achieved power ranging from 0.82 to 0.99.</p></sec></sec><sec sec-type="results" id="sec3"><label>3</label><title>RESULTS</title><sec id="sec3.1"><label>3.1</label><title>Demographic Characteristics</title><p>All 717 subjects responded to the survey and were included in the study. About two-thirds (n= 497/717) of the participants were females (69.3%). In addition, about a third (n= 215/717) of the participants belonged to the 20-25 age group. Participants were mostly represented by students (39.9%) or workers (47.3%) and had a high-school diploma (50.9%). Based on the survey responses, study participants were divided into two groups according to the presence/absence of OTC abuse/misuse (127 <italic toggle="yes">versus</italic> 590), which were compared for possible predictors of OTC diversion. Thus, similar characteristics were reported when dividing the whole sample into the two groups considering the presence of OTC abusing/misusing issues (127/717: 17.7%). Detailed socio-demographical data are reported in Table <bold><xref rid="T1" ref-type="table">1</xref></bold>.</p></sec><sec id="sec3.2"><label>3.2</label><title>Drug Knowledge and Use</title><p>Overall, a significant percentage of respondents (567 subjects: 79.1%) purchased OTC medicines without any licensed indication. Of these, approximately 43.7% had been advised to use the medicine by a family member and 21.7% by an acquaintance/friend, while others had found the suggestion on a web page (8.6%) or an online forum (1.6%). About 12.8% of the respondents used OTC combined with one or more other substances. The substances most used in combination with OTC medicines were alcohol (8.8%), prescription-only medicines (6.1%), other OTC products (4.7%), and cannabis (2.6%). Results regarding cocaine, opioids and ketamine were not statistically significant. Finally, the majority (66.0%) of the participants declared that they knew the side effects of OTC abuse/misuse. Of the entire sample, 17.7% (n=127 subjects) declared having made an abuse/misuse of OTC drugs. In the abusing/misusing group, data recorded were similar; however, interestingly, only one respondent and four responded that he had used or abused other substances than OTC medicines, such as cocaine and cannabis. The percentage of respondents who stated that they did not know the side effects of OTC drug abuse was significant (55.9%). Full data of the participant sample and the two groups of subjects are shown in Table <bold><xref rid="T1" ref-type="table">1</xref></bold>.</p></sec><sec id="sec3.3"><label>3.3</label><title>Regression Analysis</title><p>Logistic regression on OTC drug abuse/misuse [classified as 0, &#8220;non-abusing/non-misusing&#8221; or 1, &#8220;abusing/misusing&#8221;] in the model included: i) education; ii) the purchase of OTC drugs without indication (0, &#8220;no&#8221;; 1, &#8220;yes&#8221;); iii) knowing OTC drugs side effects (0, &#8220;have knowledge&#8221;; 1, &#8220;have no knowledge&#8221;); iv) age; v) gender; and vi) employment status. OTC abuse/misuse was associated with the knowledge of the substance use side effects, with an odds ratio (OR) = 2.711, 95% Confidence Interval (CI) 1.79&#8211;4.10, <italic toggle="yes">p &lt;</italic> 0.001. OTC drug abuse/misuse almost doubled when individuals purchased OTC without indication [OR = 1.54, 95% CI 1.02&#8211;2.34, <italic toggle="yes">p =</italic> 0.0<xref rid="r42" ref-type="bibr">42</xref>]. Education was also significant. Indeed, high levels of education were minimally related with OTC drugs abuse/misuse [OR = 0.695, 95% CI 0.58&#8211;0.94, <italic toggle="yes">p =</italic> 0.0<xref rid="r16" ref-type="bibr">16</xref>] (Table <bold><xref rid="T2" ref-type="table">2</xref></bold>).</p></sec></sec><sec sec-type="discussion" id="sec4"><label>4</label><title>DISCUSSION</title><p>To the best of our knowledge, this is the first study in Italy to explore this topic. Given the limited research in this area, the present study provided preliminary findings on the misuse of OTC in Italy. Indeed, the aim of the present study was to explore OTC consumption and related misuse in Italy and to identify the demographic characteristics of individuals involved in this phenomenon through a cross-sectional observational design. The main aspects investigated were the frequency of use, type of OTC used, and risk for abuse/misuse. Predictors and eventual factors which might constitute a risk for OTC abuse/misuse were also explored.</p><sec id="sec4.1"><label>4.1</label><title>Considerations on OTC Consumption and Related Misuse in Italy</title><p>As shown by the data presented here, the abuse and misuse of OTC are a considerable problem associated with a substantial risk of harm in the Italian scenario. Consistently with previous European studies [<xref rid="r48" ref-type="bibr">48</xref>-<xref rid="r50" ref-type="bibr">50</xref>], people/individuals who were here involved in this phenomenon were mainly represented by female (69.3%) students (39.9%) in the 20-25 years age group (30.0%). Data from international surveys, such as the National Surveys on Drug Use and Health in the US, showed similar trends with increasing misuse of medications, prescription psychotropics, and OTC medicines, especially in the age range 18-25 years during 2019-2020 [<xref rid="r51" ref-type="bibr">51</xref>]. A relevant part of our sample declared to misuse OTC with other substances [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r52" ref-type="bibr">52</xref>], possibly for recreational purposes (<italic toggle="yes">high)</italic> or to relax and relieve anxiety. However, many other reasons for the problematic use of OTC medicines were previously described [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r31" ref-type="bibr">31</xref>], and included the need to manage frequent headaches and chronic pains with OTC analgesics, or the management of opioid withdrawal symptoms with codeine-based medications or loperamide. Among OTC medicines, opiate-based and cough/cold products containing dextromethorphan, sleep aids, sedative antihistamines, analgesics, hypnotics, and laxatives have been highlighted as having abuse potential [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r42" ref-type="bibr">42</xref>]. The OTC codeine or other opioid-containing products and OTC cough and cold medications have been identified as the most commonly implicated medications with abuse potential [<xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r53" ref-type="bibr">53</xref>]. Moreover, together with opioids, dextromethorphan, some antihistamines such as chlorpheniramine or promethazine, and pseudoephedrine prolonged use and overdosing might result in physical, phycological, and social life consequences, but also in full substance dependence [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r54" ref-type="bibr">54</xref>] and severe outcomes which might lead to life-threatening or fatal conditions, such as the serotonin syndrome [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r55" ref-type="bibr">55</xref>]. All these consequences might clearly involve an economic cost to the health care system due to increasing hospitalisation and multiple admissions [<xref rid="r42" ref-type="bibr">42</xref>]. Therefore, this supports the need for interventions reducing the risk of OTC medicines&#8217; problematic use, including drug up-scheduling, <italic toggle="yes">e.g.</italic>, codeine was rescheduled as a prescription only medicine in some countries [<xref rid="r56" ref-type="bibr">56</xref>], or size and type sale limits, <italic toggle="yes">e.g.</italic>, loperamide has been restricted to no more than 48 mg and requiring unit-dose blister packaging in the USA by the Food and Drug Administration (FDA) [<xref rid="r57" ref-type="bibr">57</xref>].</p></sec><sec id="sec4.2"><label>4.2</label><title>Risk Factors Involved in OTC Diversion in Italy</title><p>Our study showed that purchasing OTC without licensed indications and having an eventual knowledge about their side effects are factors that might influence OTC medicines' use and diversion, which is consistent with previous studies recording users' knowledge about OTC medication uses, indications, side effects, and safety risks with prolonged use [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref>]. A survey previously conducted in Italy collected data regarding the use of OTC medications from 1,206 adults aged 18 years and older through a self-administered questionnaire, finding uncertain results regarding the non-medical use of OTC medicines (around 42% confused the concept of &#8216;contraindications&#8217; with that of &#8216;side effects&#8217;) and potential side effects, <italic toggle="yes">e.g.</italic>, most respondents were aware of the OTC general potential for side effects, but 64.3% did not know about potential harms related to the use of painkillers in people with high blood pressure and the risks of long-term use of laxatives and codeine-based nasal decongestants (58). On the other side, the educational level here appeared a protective factor [OR: 0.695], confirming previous research clearly identifying that high school dropouts and in general educational attainment have a significant relationship with substance use disorders [<xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r53" ref-type="bibr">53</xref>, <xref rid="r59" ref-type="bibr">59</xref>].</p></sec><sec id="sec4.3"><label>4.3</label><title>Prevention and Intervention Approaches</title><p>Prevention approaches should first focus on education in general and health education to support people to learn the appropriate use of OTC drugs while eliminating their misuse. Schools or other educational settings should establish programs to raise awareness among students about drug and alcohol abuse risks. Considering a common perception among youngsters that OTC drugs are safer than prescription and illegal street drugs, being unaware of the potential risks associated with their misuse, promoting the safe and proper use of OTC drugs is essential. Furthermore, the present research has shown alcohol to be the most used substance in conjunction with OTC. This result might be related to several reasons, including its wide availability, relatively low cost and dose-dependent psychoactive effects. Alcohol use might cause both short-term and long-term effects, including respectively accidental injuries, poisonings, risky sexual behaviours (which may result in unintended pregnancy or sexually transmitted diseases) and chronic diseases, such as hypertension, strokes, liver diseases, digestive problems, mental health problems, <italic toggle="yes">e.g.</italic>, depression and anxiety, social/family/job-related problems, alcohol use disorders, or alcohol dependence. Moreover, normally alcohol interacts with many drugs, including medications, OTC medicines and illegal drugs, increasing or reducing their effects, depending on the type of drug, <italic toggle="yes">e.g.</italic>, alcohol can increase the risk of drowsiness when mixed with other depressant drugs such as benzodiazepines or opioids [<xref rid="r60" ref-type="bibr">60</xref>].</p><p>Furthermore, users can take steps to ensure that they use prescription/OTC medications appropriately by i) following the directions as explained on the label or by the pharmacist; ii) being aware of potential interactions with other drugs as well as alcohol, iii) never stopping or changing a dosing regimen without first discussing it with the doctor; iv) never using another person&#8217;s prescription; v) never giving their prescription medications to others; vi) and safely storing prescription stimulants, sedatives, and opioids [<xref rid="r61" ref-type="bibr">61</xref>]. Healthcare professionals should be trained to identify and treat problematic use and know how to address signs of non-medical use of medicines optimising the appropriateness, use and safety of OTC drugs [<xref rid="r62" ref-type="bibr">62</xref>]. Moreover, offering support in primary care settings may be appropriate for people with problems associated with the non-medical use of medicines who are reluctant to seek help from traditional drug treatment services, such as professionals or non-regular drug users. Good clinical practice, supported by clear guidelines, can lower the risk of diverting and misusing medicines. In addition, pharmacists should play an increasing role in preventing the inappropriate use of medicines and reducing the associated risks and potential harms and should therefore be included in educational programmes [<xref rid="r2" ref-type="bibr">2</xref>, <xref rid="r8" ref-type="bibr">8</xref>]. Finally, public awareness and knowledge should be increased about the safe use of medications in people who might be identified as most vulnerable or at risk. Developing and implementing such responses, whether at the EU, national, local, or individual level, should involve several steps, such as the identification of the nature of the drug problems to be addressed; the selection of potentially effective interventions to tackle these problems; and the implementation and monitoring of these interventions [<xref rid="r42" ref-type="bibr">42</xref>].</p></sec><sec id="sec4.4"><label>4.4</label><title>Limitations</title><p>Despite the novelty of the study, it presented several limitations. Firstly, in being an explorative study, enrolling a self-selected sample through an online questionnaire, the generalisability of the findings could be reduced. A further limitation is related to the terminology used with regard to the definitions of <italic toggle="yes">abuse, misuse</italic>, and <italic toggle="yes">non-medical use</italic> of OTCs, which have been interchangeably used in the survey. Moreover, the engagement rate was not monitored. However, all the participating respondents provided data sufficient for the analysis of the study variables. Also, due to the cross-sectional nature of the data, no causal relationship can be drawn between the variables. Finally, using an Italian-only sample could reduce the applicability of our findings to different cultural settings.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The misuse of OTC medicines is a matter of increasing concern in Europe and is associated with acute health harms and chronic problems, such as dependence. Despite the limitations, the present study can provide important insight into the phenomenon of OTC abuse and misuse in Italy. Social education about the risks deriving from misuse of OTC drugs should play a key role in preventing strategies, particularly among those individuals at increased risk as the youngest. Policies to prevent the diffusion of OTC without prescription through the web may also be improved. Comparative data for other countries across the European Union and beyond are needed to extend and generalize our findings and improve common preventive strategies.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>Declared none.</p></ack><sec sec-type="competing-interests"><title>AUTHORS&#8217; CONTRIBUTIONS</title><p>S.C., G.M., M.D.G., and F.S focused on conceptualization. A.M., F.C., and S.C. prepared and wrote the original draft. J.B. did the statistical analysis; S.C., G.M., F.D.C, N.S., M.P., M.D.G., A.G., and J.C. wrote, reviewed and edited the manuscript. All authors have read and agreed to the published version of the manuscript.</p></sec><glossary><title>LIST OF ABBREVIATIONS</title><def-list><def-item><term>OTC</term><def><p>Over-The-Counter</p></def></def-item><def-item><term>EMCDDA</term><def><p>European Monitoring Centre for Drugs and Drug Abuse</p></def></def-item><def-item><term>MedDRA</term><def><p>Medical Dictionary for Regulatory Activities</p></def></def-item><def-item><term>NIDA</term><def><p>National Institute on Drug Abuse</p></def></def-item></def-list></glossary><sec sec-type="competing-interests"><title>ETHICS APPROVAL AND CONSENT TO PARTICIPATE</title><p>The Human Sciences Ethics Committee approved the study at the University of Hertfordshire (HSK/SF/UH/ 00104); protocol number is aLMS/SF/UH/02951 [<xref rid="r2" ref-type="bibr">2</xref>].</p></sec><sec sec-type="competing-interests"><title>HUMAN AND ANIMAL RIGHTS</title><p>No animals were used for study. All experiments involving human participants were in accordance with the Declaration of Helsinki and the European General Data Protection Regulation.</p></sec><sec sec-type="competing-interests"><title>CONSENT FOR PUBLICATION</title><p>Not applicable.</p></sec><sec sec-type="data-availability"><title>AVAILABILITY OF DATA AND MATERIALS</title><p>Not applicable.</p></sec><sec sec-type="financial-disclosure"><title>FUNDING</title><p>None.</p></sec><sec sec-type="COI-statement"><title>CONFLICT OF INTEREST</title><p>F.S. was a member of the UK Advisory Council on the Misuse of Drugs (ACMD; 2011&#8211;2019) and is currently a member of the EMA Advisory Board (Psychiatry).</p><p>J.C. is a member of the ACMD&#8217;s Novel Psychoactive Substances and Technical Committees.</p><p>G.M. has been a consultant and/or a speaker and/or has received research grants from Angelini, Doc Generici, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Servier and Recordati.</p><p>S.C., F.C., A.M., F.D.C., M.P., A. Mi., A.G., N.S., and J.B. have nothing to declare.</p><p>M.D.G. has been a consultant and/or a speaker and/or has received research grants from Angelini, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Recordati.</p></sec><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name></person-group><article-title>What about &#8220;pharming&#8221;? Issues regarding the misuse of prescription and over-the-counter drugs.</article-title><source>Brain Sci.</source><year>2020</year><volume>10</volume><issue>10</issue><fpage>736</fpage><pub-id pub-id-type="doi">10.3390/brainsci10100736</pub-id><pub-id pub-id-type="pmid">33066476</pub-id><pub-id pub-id-type="pmcid">PMC7602178</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name></person-group><article-title>Misuse of prescription and over-the-counter drugs to obtain illicit highs: How pharmacists can prevent abuse.</article-title><source>Pharm. J.</source><year>2020</year><fpage>1</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1211/PJ.2020.20208538</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miuli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mosca</surname><given-names>A.</given-names></name><name name-style="western"><surname>Santovito</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pettorruso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Di Giannantonio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Martinotti</surname><given-names>G.</given-names></name></person-group><article-title>Focus on over-the-counter drugs&#8217; misuse: A systematic review on antihistamines, cough medicines, and decongestants.</article-title><source>Front. Psychiatry</source><year>2021</year><volume>12</volume><issue>May</issue><fpage>657397</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2021.657397</pub-id><pub-id pub-id-type="pmid">34025478</pub-id><pub-id pub-id-type="pmcid">PMC8138162</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bond</surname><given-names>C.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Matheson</surname><given-names>C.</given-names></name></person-group><article-title>Changes in over-the-counter drug misuse over 20 years: Perceptions from Scottish pharmacists.</article-title><source>J. Public Health (Oxf.)</source><year>2016</year><volume>38</volume><issue>4</issue><fpage>793</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">28158745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pubmed/fdv169</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wazaify</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shields</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>McElnay</surname><given-names>J.C.</given-names></name></person-group><article-title>Societal perspectives on over-the-counter (OTC) medicines.</article-title><source>Fam. Pract.</source><year>2005</year><volume>22</volume><issue>2</issue><fpage>170</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1093/fampra/cmh723</pub-id><pub-id pub-id-type="pmid">15710640</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>McElnay</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>G.F.</given-names></name></person-group><article-title>Benefits and risks of self medication.</article-title><source>Drug Saf.</source><year>2001</year><volume>24</volume><issue>14</issue><fpage>1027</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.2165/00002018-200124140-00002</pub-id><pub-id pub-id-type="pmid">11735659</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quispe-Ca&#241;ari</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Fidel-Rosales</surname><given-names>E.</given-names></name><name name-style="western"><surname>Manrique</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mascar&#243;-Zan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huam&#225;n-Castill&#243;n</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Chamorro-Espinoza</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Garayar-Peceros</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ponce-L&#243;pez</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Sifuentes-Rosales</surname><given-names>J.</given-names></name><name name-style="western"><surname>Alvarez-Risco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Y&#225;&#241;ez</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Mejia</surname><given-names>C.R.</given-names></name></person-group><article-title>Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey.</article-title><source>Saudi Pharm. J.</source><year>2021</year><volume>29</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2020.12.001</pub-id><pub-id pub-id-type="pmid">33519270</pub-id><pub-id pub-id-type="pmcid">PMC7832015</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perrot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Citt&#233;e</surname><given-names>J.</given-names></name><name name-style="western"><surname>Louis</surname><given-names>P.</given-names></name><name name-style="western"><surname>Quentin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Robert</surname><given-names>C.</given-names></name><name name-style="western"><surname>Milon</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Bismut</surname><given-names>H.</given-names></name><name name-style="western"><surname>Baumelou</surname><given-names>A.</given-names></name></person-group><article-title>Self&#8208;medication in pain management: The state of the art of pharmacists&#8217; role for optimal over&#8208;the&#8208;counter analgesic use.</article-title><source>Eur. J. Pain</source><year>2019</year><volume>23</volume><issue>10</issue><fpage>1747</fpage><lpage>1762</lpage><pub-id pub-id-type="doi">10.1002/ejp.1459</pub-id><pub-id pub-id-type="pmid">31349370</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gracious</surname><given-names>B.</given-names></name><name name-style="western"><surname>Abe</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sundberg</surname><given-names>J.</given-names></name></person-group><article-title>The importance of taking a history of over-the-counter medication use: A brief review and case illustration of &#8220;PRN&#8221; antihistamine dependence in a hospitalized adolescent.</article-title><source>J. Child Adolesc. Psychopharmacol.</source><year>2010</year><volume>20</volume><issue>6</issue><fpage>521</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1089/cap.2010.0031</pub-id><pub-id pub-id-type="pmid">21186972</pub-id><pub-id pub-id-type="pmcid">PMC3025184</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="book"><collab>NIDA National Institute on Drug Abuse</collab><source>Research report series.</source><publisher-name>Prescription Drug Abuse</publisher-name><year>2011</year></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>D.A.</given-names></name></person-group><article-title>&#8216;Pharming&#8217;: The abuse of prescription and over-the-counter drugs in teens.</article-title><source>Curr. Opin. Pediatr.</source><year>2007</year><volume>19</volume><issue>3</issue><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1097/MOP.0b013e32814b09cf</pub-id><pub-id pub-id-type="pmid">17505185</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>S.</given-names></name><name name-style="western"><surname>Meisner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>S.</given-names></name></person-group><article-title>What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations.</article-title><source>Curr. Drug Abuse Rev.</source><year>2008</year><volume>1</volume><issue>3</issue><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.2174/1874473710801030255</pub-id><pub-id pub-id-type="pmid">19630724</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novak</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>H&#229;kansson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Martinez-Raga</surname><given-names>J.</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Krotki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Varughese</surname><given-names>S.</given-names></name></person-group><article-title>Nonmedical use of prescription drugs in the European Union.</article-title><source>BMC Psychiatry</source><year>2016</year><volume>16</volume><issue>1</issue><fpage>274</fpage><pub-id pub-id-type="doi">10.1186/s12888-016-0909-3</pub-id><pub-id pub-id-type="pmid">27488186</pub-id><pub-id pub-id-type="pmcid">PMC4972971</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffiths</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>M.W.</given-names></name></person-group><article-title>Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds.</article-title><source>J. Clin. Psychiatry</source><year>2005</year><volume>66</volume><issue>Suppl. 9</issue><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">16336040</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oyekan</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Gorton</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Copeland</surname><given-names>C.S.</given-names></name></person-group><article-title>Antihistamine&#8208;related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use?</article-title><source>Br. J. Clin. Pharmacol.</source><year>2021</year><volume>87</volume><issue>10</issue><fpage>3978</fpage><lpage>3987</lpage><pub-id pub-id-type="doi">10.1111/bcp.14819</pub-id><pub-id pub-id-type="pmid">33729599</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name></person-group><article-title>Beyond the &#8216;purple drank&#8217;: Study of promethazine abuse according to the european medicines agency adverse drug reaction reports.</article-title><source>J. Psychopharmacol.</source><year>2021</year><volume>35</volume><issue>6</issue><fpage>681</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1177/0269881120959615</pub-id><pub-id pub-id-type="pmid">33427017</pub-id><pub-id pub-id-type="pmcid">PMC8278560</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miuli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stigliano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lalli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Coladonato</surname><given-names>M.</given-names></name><name name-style="western"><surname>D&#8217;Angelo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Esposito</surname><given-names>F.</given-names></name><name name-style="western"><surname>Cappello</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pettorruso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Martinotti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Di Giannantonio</surname><given-names>M.</given-names></name></person-group><article-title>&#8220;Purple Drank&#8221; (codeine and promethazine cough syrup): A systematic review of a social phenomenon with medical implications.</article-title><source>J. Psychoactive Drugs</source><year>2020</year><volume>52</volume><issue>5</issue><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1080/02791072.2020.1797250</pub-id><pub-id pub-id-type="pmid">32748711</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Hout</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Norman</surname><given-names>I.</given-names></name></person-group><article-title>Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.</article-title><source>Int. J. Drug Policy</source><year>2016</year><volume>27</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.drugpo.2015.09.007</pub-id><pub-id pub-id-type="pmid">26454626</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Miech</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Bachman</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Schulenberg</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>M.E.</given-names></name></person-group><comment>Monitoring the future: National
survey results on drug use 1975-2021. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://deepblue.lib.umich.edu/bitstream/handle/2027.42/171751/mtf" ext-link-type="uri">https://deepblue.lib.umich.edu/bitstream/handle/2027.42/171751/mtf</ext-link></comment></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berman</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Setty</surname><given-names>A.</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Skotzko</surname><given-names>C.</given-names></name></person-group><article-title>Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids.</article-title><source>J. Addict. Dis.</source><year>2006</year><volume>25</volume><issue>3</issue><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1300/J069v25n03_06</pub-id><pub-id pub-id-type="pmid">16956868</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>H.</given-names></name><name name-style="western"><surname>Panahi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tapia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>J.D.</given-names></name></person-group><article-title>Loperamide misuse and abuse.</article-title><source>J. Am. Pharm. Assoc. (Wash. D.C.)</source><year>2017</year><volume>57</volume><issue>2</issue><fpage>S45</fpage><lpage>S50</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2016.12.079</pub-id><pub-id pub-id-type="pmid">28189538</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name></person-group><article-title>Is there such a thing as a &#8216;lope&#8217; dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>10</issue><fpage>e0204443</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0204443</pub-id><pub-id pub-id-type="pmid">30286103</pub-id><pub-id pub-id-type="pmcid">PMC6171858</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaprutko</surname><given-names>T.</given-names></name><name name-style="western"><surname>Koligat</surname><given-names>D.</given-names></name><name name-style="western"><surname>Michalak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wieczorek</surname><given-names>M.</given-names></name><name name-style="western"><surname>J&#243;ziak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ratajczak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Szyd&#322;owska</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miazek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kus</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nowakowska</surname><given-names>E.</given-names></name></person-group><article-title>Misuse of OTC drugs in Poland.</article-title><source>Health Policy</source><year>2016</year><volume>120</volume><issue>8</issue><fpage>875</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1016/j.healthpol.2016.06.008</pub-id><pub-id pub-id-type="pmid">27344198</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stefania</surname><given-names>C.</given-names></name><name name-style="western"><surname>Andrea</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alessio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mauro</surname><given-names>P.</given-names></name><name name-style="western"><surname>Amira</surname><given-names>G.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Giovanni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fabrizio</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name></person-group><article-title>The benzydamine experience: A systematic review of benzydamine abuse.</article-title><source>Curr. Neuropharmacol.</source><year>2021</year><volume>19</volume><issue>10</issue><fpage>1728</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.2174/1570159X19666210113151136</pub-id><pub-id pub-id-type="pmid">33441070</pub-id><pub-id pub-id-type="pmcid">PMC8977632</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>D.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>K.</given-names></name><name name-style="western"><surname>Stuart</surname><given-names>J.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>D.</given-names></name></person-group><article-title>Misuse of over the counter medicines in community pharmacies in Scotland.</article-title><source>J. Subst. Use</source><year>2018</year><volume>23</volume><issue>1</issue><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1080/14659891.2017.1316783</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>S.</given-names></name><name name-style="western"><surname>Annand</surname><given-names>F.</given-names></name><name name-style="western"><surname>Burkinshaw</surname><given-names>P.</given-names></name><name name-style="western"><surname>Greaves</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Knight</surname><given-names>J.</given-names></name></person-group><comment>Dependence and withdrawal associated with some prescribed
medicines. An evidence review. Public Heal England,
London, 2019, 89-92. Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.facebook.com/PublicHealthEngland%0Ahttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/829777/PHE_PMR_report.pdf">www.facebook.com/PublicHealth
England% 0A https://assets.publishing.service.gov.uk/
government/uploads/system/uploads/attachment_data/file/829777/
PHE_PMR_report.pdf</uri></comment></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fingleton</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Watson</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Matheson</surname><given-names>C.</given-names></name></person-group><article-title>Non-prescription medicine misuse, abuse and dependence: A cross-sectional survey of the UK general population.</article-title><source>J. Public Health (Oxf.)</source><year>2016</year><volume>38</volume><issue>4</issue><fpage>fdv204</fpage><pub-id pub-id-type="doi">10.1093/pubmed/fdv204</pub-id><pub-id pub-id-type="pmid">28158728</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Algarni</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hadi</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Yahyouche</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mahmood</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jalal</surname><given-names>Z.</given-names></name></person-group><article-title>A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults.</article-title><source>J. Pharm. Policy Pract.</source><year>2021</year><volume>14</volume><issue>1</issue><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s40545-021-00350-7</pub-id><pub-id pub-id-type="pmid">34517925</pub-id><pub-id pub-id-type="pmcid">PMC8439034</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hodgkinson</surname><given-names>J.</given-names></name></person-group><article-title>Quality evaluation of community pharmacy blood pressure (BP) screening services: An English cross-sectional survey with geospatial analysis.</article-title><source>BMJ Open</source><year>2019</year><volume>9</volume><issue>12</issue><fpage>e032342</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2019-032342</pub-id><pub-id pub-id-type="pmid">31831543</pub-id><pub-id pub-id-type="pmcid">PMC6924779</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weidmann</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hansford</surname><given-names>D.</given-names></name><name name-style="western"><surname>McLay</surname><given-names>J.</given-names></name><name name-style="western"><surname>Broom</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>D.</given-names></name></person-group><article-title>Over-the-counter orlistat: Early experiences, views and attitudes of community pharmacists in Great Britain.</article-title><source>Int. J. Clin. Pharm.</source><year>2011</year><volume>33</volume><issue>4</issue><fpage>627</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1007/s11096-011-9516-z</pub-id><pub-id pub-id-type="pmid">21573977</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sansgiry</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bhansali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bapat</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name></person-group><article-title>Abuse of over-the-counter medicines: A pharmacist&#8217;s perspective.</article-title><source>Integr. Pharm. Res. Pract.</source><year>2016</year><volume>6</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.2147/IPRP.S103494</pub-id><pub-id pub-id-type="pmid">29354545</pub-id><pub-id pub-id-type="pmcid">PMC5774309</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abraham</surname><given-names>O.</given-names></name></person-group><article-title>Chmielinski, J. Adolescents&#8217; misuse of over-the-counter medications: The need for pharmacist-led intervention.</article-title><source>Innov. Pharm.</source><year>2018</year><volume>9</volume><issue>3</issue><fpage>4</fpage><pub-id pub-id-type="doi">10.24926/iip.v9i3.979</pub-id><pub-id pub-id-type="pmid">34007709</pub-id><pub-id pub-id-type="pmcid">PMC6302752</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name><name name-style="western"><surname>John</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name></person-group><article-title>COVID-19: The hidden impact on mental health and drug addiction.</article-title><source>Front. Psychiatry</source><year>2020</year><volume>11</volume><fpage>767</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2020.00767</pub-id><pub-id pub-id-type="pmid">32848937</pub-id><pub-id pub-id-type="pmcid">PMC7403495</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="other"><comment>UNODC. World drug report 2021-covid-19 and drugs: Impact
outlook. United Nat. Vienna, 2021. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_5.pdf" ext-link-type="uri">https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_5.pdf</ext-link></comment></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="book"><collab>National Institute on Drug Abuse</collab><source>Misuse of prescription drugs research report</source><year>2020</year><fpage>1</fpage><lpage>29</lpage><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.drugabuse.gov/publications/research-reports/misuseprescription-drugs/what-scope-prescription-drug-misuse">https://www.drugabuse.gov/publications/research-reports/misuseprescription-
drugs/what-scope-prescription-drug-misuse</uri></comment></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinotti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Alessi</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Di Natale</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sociali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ceci</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lucidi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Picutti</surname><given-names>E.</given-names></name><name name-style="western"><surname>Di Carlo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Corbo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vellante</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fiori</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tourjansky</surname><given-names>G.</given-names></name><name name-style="western"><surname>Catalano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Carenti</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Incerti</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Bartoletti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Barlati</surname><given-names>S.</given-names></name><name name-style="western"><surname>Romeo</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Verrastro</surname><given-names>V.</given-names></name><name name-style="western"><surname>De Giorgio</surname><given-names>F.</given-names></name><name name-style="western"><surname>Valchera</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sepede</surname><given-names>G.</given-names></name><name name-style="western"><surname>Casella</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pettorruso</surname><given-names>M.</given-names></name><name name-style="western"><surname>di Giannantonio</surname><given-names>M.</given-names></name></person-group><article-title>Psychopathological burden and quality of life in substance users during the covid-19 lockdown period in Italy.</article-title><source>Front. Psychiatry</source><year>2020</year><volume>11</volume><issue>September</issue><fpage>572245</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2020.572245</pub-id><pub-id pub-id-type="pmid">33101086</pub-id><pub-id pub-id-type="pmcid">PMC7497905</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brusa</surname><given-names>P.</given-names></name><name name-style="western"><surname>Allais</surname><given-names>G.</given-names></name><name name-style="western"><surname>Scarinzi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Baratta</surname><given-names>F.</given-names></name><name name-style="western"><surname>Parente</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rolando</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gnavi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Spadea</surname><given-names>T.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>G.</given-names></name><name name-style="western"><surname>Benedetto</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mana</surname><given-names>M.</given-names></name><name name-style="western"><surname>Giaccone</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mandelli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Manzoni</surname><given-names>G.C.</given-names></name><name name-style="western"><surname>Bussone</surname><given-names>G.</given-names></name></person-group><article-title>Self-medication for migraine: A nationwide cross-sectional study in Italy.</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>1</issue><fpage>e0211191</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0211191</pub-id><pub-id pub-id-type="pmid">30673780</pub-id><pub-id pub-id-type="pmcid">PMC6343913</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingrasciotta</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>J.</given-names></name><name name-style="western"><surname>Giorgianni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Menditto</surname><given-names>E.</given-names></name><name name-style="western"><surname>Scuteri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tari</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tari</surname><given-names>D.U.</given-names></name><name name-style="western"><surname>Basile</surname><given-names>G.</given-names></name><name name-style="western"><surname>Trifiro&#8217;</surname><given-names>G.</given-names></name></person-group><article-title>Analgesic drug use in elderly persons: A population-based study in Southern Italy.</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>9</issue><fpage>e0222836</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0222836</pub-id><pub-id pub-id-type="pmid">31536588</pub-id><pub-id pub-id-type="pmcid">PMC6752879</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navaro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vezzosi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Santagati</surname><given-names>G.</given-names></name><name name-style="western"><surname>Angelillo</surname><given-names>I.F.</given-names></name></person-group><article-title>Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy.</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>6</issue><fpage>e0198618</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0198618</pub-id><pub-id pub-id-type="pmid">29920515</pub-id><pub-id pub-id-type="pmcid">PMC6007931</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otto</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Pillarella</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jommi</surname><given-names>C.</given-names></name></person-group><article-title>The economic impact of a switch from prescription-only to nonprescription drugs in Italy.</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><issue>OCT</issue><fpage>1069</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.01069</pub-id><pub-id pub-id-type="pmid">30386233</pub-id><pub-id pub-id-type="pmcid">PMC6199397</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="other"><comment>ICH. Meddra &#174; term selection: Points to consider. ich-endorsed
guide for MedDRA users. London, <bold>2014</bold>, pp. 1-49.</comment></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><collab>European Monitoring Centre for Drugs and Drug Addiction</collab><source>Non-medical use of medicines: Health and social responses</source><year>2021</year><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.emcdda.europa.eu/publications/mini-guides/non-medical-use-of-medicines-health-and-social-responses_en">https://www.emcdda.europa.eu/publications/mini-guides/non-medical-use-of-medicines-health-and-social-responses_en</uri></comment></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="other"><comment>NIDA National Institute on Drug Abuse. The science of drug use
and addiction: The basics | NIDA archives. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://archives.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics" ext-link-type="uri">https://archives.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics</ext-link></comment></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="other"><comment>National Collaborating Centre for Mental Health (UK). 2008.
Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK53217/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK53217/</ext-link></comment></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Napoletano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Bonaccorso</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ricciardi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scherbaum</surname><given-names>N.</given-names></name><name name-style="western"><surname>Vento</surname><given-names>A.</given-names></name></person-group><article-title>New/emerging psychoactive substances and associated psychopathological consequences &#8211; Corrigendum.</article-title><source>Psychol. Med.</source><year>2021</year><volume>51</volume><issue>1</issue><fpage>43</fpage><pub-id pub-id-type="doi">10.1017/S003329171900254X</pub-id><pub-id pub-id-type="pmid">31511097</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Stinson</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Hasin</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Saha</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Grant</surname><given-names>B.F.</given-names></name></person-group><article-title>Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions.</article-title><source>J. Clin. Psychiatry</source><year>2006</year><volume>67</volume><issue>7</issue><fpage>1062</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.4088/JCP.v67n0708</pub-id><pub-id pub-id-type="pmid">16889449</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faugier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sargeant</surname><given-names>M.</given-names></name></person-group><article-title>Sampling hard to reach populations.</article-title><source>J. Adv. Nurs.</source><year>1997</year><volume>26</volume><issue>4</issue><fpage>790</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2648.1997.00371.x</pub-id><pub-id pub-id-type="pmid">9354993</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="other"><collab>European Commission, Directorate-General for Research &amp; Innovation.
Horizon 2020 programme - Guidance How to complete
your ethics self-assessment V6.1</collab><source>Eur Comm Dir Res Innov</source><year>2019</year><comment>43. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://ec.europa.eu/research/participants/data/" ext-link-type="uri">http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/h2020_hi_ethics-selfassess_
en.pdf</ext-link></comment></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casati</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sedefov</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pfeiffer-Gerschel</surname><given-names>T.</given-names></name></person-group><article-title>Misuse of medicines in the European Union: A systematic review of the literature.</article-title><source>Eur. Addict. Res.</source><year>2012</year><volume>18</volume><issue>5</issue><fpage>228</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1159/000337028</pub-id><pub-id pub-id-type="pmid">22572594</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colomer-P&#233;rez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chover-Sierra</surname><given-names>E.</given-names></name><name name-style="western"><surname>Navarro-Mart&#237;nez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Andriusevi&#269;ien&#279;</surname><given-names>V.</given-names></name><name name-style="western"><surname>Vlachou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Cauli</surname><given-names>O.</given-names></name></person-group><article-title>Alcohol and drug use in
european university health science students: Relationship with selfcare
ability.</article-title><source>Intern journ env res publ health</source><year>2019</year><volume>16</volume><issue>24</issue><fpage>5042</fpage><pub-id pub-id-type="doi">10.3390/ijerph16245042</pub-id><pub-id pub-id-type="pmcid">PMC6949914</pub-id><pub-id pub-id-type="pmid">31835685</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="webpage"><collab>Substance Abuse and Mental Health Services Administration
(SAMHSA). 2020 National Survey of Drug Use and Health
(NSDUH) releases</collab><year>2020</year><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and">https://www.samhsa.
gov/data/release/2020-national-survey-drug-use-and</uri></comment></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lessenger</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Feinberg</surname><given-names>S.D.</given-names></name></person-group><article-title>Abuse of prescription and over-the-counter medications.</article-title><source>J. Am. Board Fam. Med.</source><year>2008</year><volume>21</volume><issue>1</issue><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.3122/jabfm.2008.01.070071</pub-id><pub-id pub-id-type="pmid">18178702</pub-id></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>R.J.</given-names></name></person-group><article-title>Over-the-counter medicine abuse &#8211; a review of the literature.</article-title><source>J. Subst. Use</source><year>2013</year><volume>18</volume><issue>2</issue><fpage>82</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.3109/14659891.2011.615002</pub-id><pub-id pub-id-type="pmid">23525509</pub-id><pub-id pub-id-type="pmcid">PMC3603170</pub-id></element-citation></ref><ref id="r54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>R.J.</given-names></name></person-group><article-title>&#8216;I can&#8217;t be an addict. I am.&#8217; Over-the-counter medicine abuse: A qualitative study.</article-title><source>BMJ Open</source><year>2013</year><volume>3</volume><issue>6</issue><fpage>e002913</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2013-002913</pub-id><pub-id pub-id-type="pmid">23794565</pub-id><pub-id pub-id-type="pmcid">PMC3693421</pub-id></element-citation></ref><ref id="r55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schifano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chiappini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miuli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corkery</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Scherbaum</surname><given-names>N.</given-names></name><name name-style="western"><surname>Napoletano</surname><given-names>F.</given-names></name><name name-style="western"><surname>Arillotta</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zangani</surname><given-names>C.</given-names></name><name name-style="western"><surname>Catalani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Vento</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pettorruso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Martinotti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Massimo</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Guirguis</surname><given-names>A.</given-names></name></person-group><article-title>New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.</article-title><source>Exp. Neurol.</source><year>2021</year><volume>339</volume><issue>February</issue><fpage>113638</fpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2021.113638</pub-id><pub-id pub-id-type="pmid">33571533</pub-id></element-citation></ref><ref id="r56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaffer</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Cairns</surname><given-names>R.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Gisev</surname><given-names>N.</given-names></name><name name-style="western"><surname>Buckley</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>S.A.</given-names></name></person-group><article-title>Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.</article-title><source>Med. J. Aust.</source><year>2020</year><volume>212</volume><issue>7</issue><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.5694/mja2.50552</pub-id><pub-id pub-id-type="pmid">32200566</pub-id></element-citation></ref><ref id="r57"><label>57</label><element-citation publication-type="journal"><collab>Food and Drug Administration (FDA)</collab><source>FDA drug safety communication: FDA limits packaging for anti-diarrhea medicine loperamide (Imodium) to encourage safe use.</source><year>2019</year><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-limits-packaging-anti-diarrhea-medicine-loperamide-imodium-encourage-safe-use">https://www.fda.gov/drugs/drug-safety-and-availability/fda-limits-packaging-anti-diarrhea-medicine-loperamide-imodium-encourage-safe-use</uri></comment></element-citation></ref><ref id="r58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calamusa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Di Marzio</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cristofani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Arrighetti</surname><given-names>P.</given-names></name><name name-style="western"><surname>Santaniello</surname><given-names>V.</given-names></name><name name-style="western"><surname>Alfani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carducci</surname><given-names>A.</given-names></name></person-group><article-title>Factors that influence Italian consumers&#8217; understanding of over-the-counter medicines and risk perception.</article-title><source>Patient Educ. Couns.</source><year>2012</year><volume>87</volume><issue>3</issue><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2011.10.003</pub-id><pub-id pub-id-type="pmid">22119713</pub-id></element-citation></ref><ref id="r59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ford</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Pomykacz</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>K.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Schepis</surname><given-names>T.S.</given-names></name></person-group><article-title>Educational attainment and prescription drug misuse: The importance of push and pull factors for dropping out.</article-title><source>J. Crim. Justice</source><year>2020</year><volume>66</volume><fpage>101636</fpage><pub-id pub-id-type="doi">10.1016/j.jcrimjus.2019.101636</pub-id><pub-id pub-id-type="pmid">32863457</pub-id><pub-id pub-id-type="pmcid">PMC7449532</pub-id></element-citation></ref><ref id="r60"><label>60</label><element-citation publication-type="journal"><collab>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</collab><source>Harmful Interactions- mixing alcohol with medicines. NIH Publ No 13&#8211;5329</source><year>2014</year><comment>Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/harmful-interactions-mixing-alcohol-with-medicines">https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/harmful-interactions-mixing-alcohol-with-medicines</uri></comment></element-citation></ref><ref id="r61"><label>61</label><element-citation publication-type="other"><comment>NIDA National Institute on Drug Abuse. How can prescription
drug misuse be prevented? [cited 2022 Sept 27 Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription-drug-misuse-be-prevented">https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription-drug-misuse-be-prevented</uri></comment></element-citation></ref><ref id="r62"><label>62</label><element-citation publication-type="other"><comment>National Health System (NHS). Prescribing of medicines that are
available for purchase (Self-Care). 2020. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.thurrockccg.nhs.uk/about-us/document-library/medicines-management/position-statements/4382-medicines-that-are-available-for-purchase-over-the-counter-may-2020/file" ext-link-type="uri">https://www.thurrockccg.nhs.uk/about-us/document-library/medicines-management/position-statements/4382-medicines-that-are-available-for-purchase-over-the-counter-may-2020/file</ext-link></comment></element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Demographic characteristics of study participants.</p></caption><table frame="border" rules="all" width="100%"><tbody><tr><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">
<bold>-</bold>
</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Total</bold>
</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Non Abusing/</bold>
<break/>
<bold>Misusing</bold>
</th><th valign="middle" align="center" scope="col" rowspan="1" colspan="1">
<bold>Abusing/</bold>
<break/>
<bold>Misusing</bold>
</th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">
<bold>&#967;<sup>2</sup></bold>
</th><th rowspan="2" valign="middle" align="center" scope="col" colspan="1">
<bold>P</bold>
</th></tr><tr><td valign="middle" colspan="1" align="center" scope="row" rowspan="1">
<bold>N=717</bold>
</td><td valign="middle" align="center" rowspan="1" colspan="1">
<bold>N=590</bold>
</td><td valign="middle" align="center" rowspan="1" colspan="1">
<bold>N=127</bold>
</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Age</td><td valign="middle" align="center" rowspan="1" colspan="1">14.527</td><td valign="middle" align="center" rowspan="1" colspan="1">.024</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">15-20 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">53(7.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">42(7.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">11(8.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">20-25 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">215(30.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">170(28.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">45(35.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">25-30 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">133(18.5%)</td><td valign="middle" align="center" rowspan="1" colspan="1">114(19.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">19(15.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">30-35 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">76(10.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">67(11.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">9(7.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">35-45 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">94(13.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">86(14.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">8(6.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.012</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">45-65 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">125(17.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">94(15.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">31(24.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.022</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Over 65 yrs.</td><td valign="middle" align="center" rowspan="1" colspan="1">21(2.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">17(2.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">4(3.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Gender</td><td valign="middle" align="center" rowspan="1" colspan="1">5.476</td><td valign="middle" align="center" rowspan="1" colspan="1">.019</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Male</td><td valign="middle" align="center" rowspan="1" colspan="1">220(30.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">170(28.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">50(39.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Female</td><td valign="middle" align="center" rowspan="1" colspan="1">497(69.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">420(71.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">77(60.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Occupation</td><td valign="middle" align="center" rowspan="1" colspan="1">6.760</td><td valign="middle" align="center" rowspan="1" colspan="1">.080</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Student</td><td valign="middle" align="center" rowspan="1" colspan="1">286(39.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">229(38.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">57(44.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Worker</td><td valign="middle" align="center" rowspan="1" colspan="1">339(47.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">291(49.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">48(37.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.019</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Unemployed</td><td valign="middle" align="center" rowspan="1" colspan="1">51(7.1%</td><td valign="middle" align="center" rowspan="1" colspan="1">40(6.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">11(8.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Retired</td><td valign="middle" align="center" rowspan="1" colspan="1">41(5.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">30(5.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">11(8.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Employed</td><td valign="middle" align="center" rowspan="1" colspan="1">5.571</td><td valign="middle" align="center" rowspan="1" colspan="1">.018</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">No</td><td valign="middle" align="center" rowspan="1" colspan="1">378(52.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">299(50.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">79(62.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Yes</td><td valign="middle" align="center" rowspan="1" colspan="1">339(47.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">291(49.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">48(37.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Education</td><td valign="middle" align="center" rowspan="1" colspan="1">12.957</td><td valign="middle" align="center" rowspan="1" colspan="1">.004</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Middle school diploma</td><td valign="middle" align="center" rowspan="1" colspan="1">65(9.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">46(7.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">19(15.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.011</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">High school diploma</td><td valign="middle" align="center" rowspan="1" colspan="1">365(50.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">293(49.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">72(56.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Degree</td><td valign="middle" align="center" rowspan="1" colspan="1">235(32.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">203(34.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">32(25.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.045</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Postgraduate qualification</td><td valign="middle" align="center" rowspan="1" colspan="1">52(7.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">48(8.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">4(3.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.048</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Purchased an otc drug without indication</td><td valign="middle" align="center" rowspan="1" colspan="1">4.111</td><td valign="middle" align="center" rowspan="1" colspan="1">.043</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">No</td><td valign="middle" align="center" rowspan="1" colspan="1">150(20.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">115(19.5%)</td><td valign="middle" align="center" rowspan="1" colspan="1">35(27.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Yes</td><td valign="middle" align="center" rowspan="1" colspan="1">567(79.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">475(80.5%)</td><td valign="middle" align="center" rowspan="1" colspan="1">92(72.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Familiar</td><td valign="middle" align="center" rowspan="1" colspan="1">248(43.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">207(43.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">41(44.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.030</td><td valign="middle" align="center" rowspan="1" colspan="1">.861</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Acquaintance/friend</td><td valign="middle" align="center" rowspan="1" colspan="1">123(21.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">99(20.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">24(26.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.248</td><td valign="middle" align="center" rowspan="1" colspan="1">.264</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Web page</td><td valign="middle" align="center" rowspan="1" colspan="1">49(8.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">42(8.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">7(7.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.149</td><td valign="middle" align="center" rowspan="1" colspan="1">.700</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Forum online</td><td valign="middle" align="center" rowspan="1" colspan="1">9(1.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">7(1.5%)</td><td valign="middle" align="center" rowspan="1" colspan="1">2(2.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.242</td><td valign="middle" align="center" rowspan="1" colspan="1">.644</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Concomitant substance use</td><td valign="middle" align="center" rowspan="1" colspan="1">0.626</td><td valign="middle" align="center" rowspan="1" colspan="1">.429</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">No</td><td valign="middle" align="center" rowspan="1" colspan="1">625(87.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">517(87.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">108(85.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Yes</td><td valign="middle" align="center" rowspan="1" colspan="1">92(12.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">73(12.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">19(15.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Alcohol</td><td valign="middle" align="center" rowspan="1" colspan="1">63(8.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">54(9.2%)</td><td valign="middle" align="center" rowspan="1" colspan="1">9(7.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.557</td><td valign="middle" align="center" rowspan="1" colspan="1">.456</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Prescription drugs</td><td valign="middle" align="center" rowspan="1" colspan="1">44(6.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">36(6.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">8(6.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.007</td><td valign="middle" align="center" rowspan="1" colspan="1">.933</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Over-the-counter medications</td><td valign="middle" align="center" rowspan="1" colspan="1">34(4.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">24(4.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">10(7.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">3.352</td><td valign="middle" align="center" rowspan="1" colspan="1">.067</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Cannabis</td><td valign="middle" align="center" rowspan="1" colspan="1">19(2.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">15(2.5%)</td><td valign="middle" align="center" rowspan="1" colspan="1">4(3.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.149</td><td valign="middle" align="center" rowspan="1" colspan="1">.759</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Cocaine</td><td valign="middle" align="center" rowspan="1" colspan="1">3(0.4%)</td><td valign="middle" align="center" rowspan="1" colspan="1">2(0.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">1(0.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.504</td><td valign="middle" align="center" rowspan="1" colspan="1">.443</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Opioids</td><td valign="middle" align="center" rowspan="1" colspan="1">2(0.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0(0.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">2(1.6%)</td><td valign="middle" align="center" rowspan="1" colspan="1">9.317</td><td valign="middle" align="center" rowspan="1" colspan="1">.031</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Ketamine</td><td valign="middle" align="center" rowspan="1" colspan="1">1(0.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">0(0.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">1(0.8%)</td><td valign="middle" align="center" rowspan="1" colspan="1">4.652</td><td valign="middle" align="center" rowspan="1" colspan="1">.177</td></tr><tr><td valign="middle" colspan="4" align="center" scope="row" rowspan="1">Knowledge of otc drugs misuse/abuse side effects</td><td valign="middle" align="center" rowspan="1" colspan="1">32.896</td><td valign="middle" align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">Yes</td><td valign="middle" align="center" rowspan="1" colspan="1">473(66.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">417(70.7%)</td><td valign="middle" align="center" rowspan="1" colspan="1">56(44.1%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="middle" align="center" scope="row" rowspan="1" colspan="1">No</td><td valign="middle" align="center" rowspan="1" colspan="1">244(34.0%)</td><td valign="middle" align="center" rowspan="1" colspan="1">173(29.3%)</td><td valign="middle" align="center" rowspan="1" colspan="1">71(55.9%)</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><p><bold>Abbreviations:</bold> OTC: over-the-counter; yrs: years</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Logistic regression model of factors associated with OCT abuse/misuse.</p></caption><table frame="border" rules="all" width="100%"><tbody><tr><td rowspan="9" valign="middle" align="center" scope="col" colspan="1">Total N=717 (Non abusing/ misusing: n = 590)/ Abusing/ misusing: n = 127)</td><td rowspan="2" valign="middle" colspan="2" align="center" scope="colgroup">
<bold>Variables</bold>
</td><td rowspan="2" valign="middle" align="center" scope="col" colspan="1">
<bold>OR</bold>
</td><td valign="middle" colspan="3" align="center" scope="colgroup" rowspan="1">
<bold>CI</bold>
</td><td rowspan="2" valign="middle" align="center" scope="col" colspan="1">
<bold>p</bold>
</td></tr><tr><td valign="middle" colspan="1" align="center" scope="row" rowspan="1">
<bold>Min</bold>
</td><td valign="middle" colspan="2" align="center" rowspan="1">
<bold>Max</bold>
</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Age</td><td valign="middle" align="center" rowspan="1" colspan="1">.994</td><td valign="middle" align="center" rowspan="1" colspan="1">.878</td><td valign="middle" colspan="2" align="center" rowspan="1">1.125</td><td valign="middle" align="center" rowspan="1" colspan="1">.923</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Gender</td><td valign="middle" align="center" rowspan="1" colspan="1">.822</td><td valign="middle" align="center" rowspan="1" colspan="1">.534</td><td valign="middle" colspan="2" align="center" rowspan="1">1.265</td><td valign="middle" align="center" rowspan="1" colspan="1">.373</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Employed</td><td valign="middle" align="center" rowspan="1" colspan="1">.767</td><td valign="middle" align="center" rowspan="1" colspan="1">.477</td><td valign="middle" colspan="2" align="center" rowspan="1">1.235</td><td valign="middle" align="center" rowspan="1" colspan="1">.275</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Educational level</td><td valign="middle" align="center" rowspan="1" colspan="1">.695</td><td valign="middle" align="center" rowspan="1" colspan="1">.517</td><td valign="middle" colspan="2" align="center" rowspan="1">.935</td><td valign="middle" align="center" rowspan="1" colspan="1">.016</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Purchase of OTC drugs without indication</td><td valign="middle" align="center" rowspan="1" colspan="1">1.542</td><td valign="middle" align="center" rowspan="1" colspan="1">1.017</td><td valign="middle" colspan="2" align="center" rowspan="1">2.339</td><td valign="middle" align="center" rowspan="1" colspan="1">.042</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Knowledge of OTC<break/>drugs misuse/abuse<break/>side effects</td><td valign="middle" align="center" rowspan="1" colspan="1">2.711</td><td valign="middle" align="center" rowspan="1" colspan="1">1.794</td><td valign="middle" colspan="2" align="center" rowspan="1">4.097</td><td valign="middle" align="center" rowspan="1" colspan="1">&lt; .001</td></tr><tr><td valign="middle" colspan="2" align="center" scope="row" rowspan="1">Constant</td><td valign="middle" align="center" rowspan="1" colspan="1">.410</td><td valign="middle" align="center" rowspan="1" colspan="1">-</td><td valign="middle" colspan="2" align="center" rowspan="1">-</td><td valign="middle" align="center" rowspan="1" colspan="1">.122</td></tr></tbody></table><table-wrap-foot><p><bold>Abbreviations:</bold> CI: Confidence Interval; Odds Ratio: OR; OTC: over-the-counter</p><p><bold>Note:</bold> Gender &#8211; male (1)/female (2); Employed &#8211; No (0), Yes (1); Purchase over-the-counter drug without indication &#8211; No (0), Yes (1); Have no knowledge &#8211; have (0), No have/I have never used the previous drugs (1).</p></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>